Back to MW MARSHALL WACE, LLP

RGENRGEN
Showing 8 of 31 quarters

Position history for MWMARSHALL WACE, LLP's holdings in REPLIGEN CORP

MARSHALL WACE, LLP holds 282,107 shares of RGEN (REPLIGEN CORP), worth $38.5M as of 2026-Q2. This is a new position. RGEN represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$38.5M

Current Shares

282,107

Total Value Change

+$3.2M

Total Shares Change

+44,885

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
282,107
-
$38.5M0.0%$136.44
40
2026-Q1
Exited
0
-100.0%
$00.0%$123.06
0
2025-Q4
Increased
516,336
+185.2%
$84.6M0.1%$166.59
48
2025-Q3
Increased
181,063
+115.0%
$24.2M0.0%$124.09
46
2025-Q2
Decreased
84,195
-0.7%
$10.5M0.0%$123.56
0
2025-Q1
Decreased
84,768
-79.4%
$10.8M0.0%$133.41
0
2024-Q4
Increased
412,235
+73.8%
$59.3M0.1%$143.81
44
2024-Q3
Decreased
237,222
-34.9%
$35.3M0.0%$145.93
0

Other major holders of RGEN: BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc., BlackRock, Inc., PRICE T ROWE ASSOCIATES INC /MD/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used